Holocene Advisors’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
Other funds holding CNMD
VPM
VCM
CB
Holocene Advisors's CNMD Position: Q1 2026 in Review
Holocene Advisors sold out of CONMED (CNMD) in Q1 2026, closing a stake of 11,463 shares — an estimated $465K sold.
Holocene Advisors first reported a position in CNMD in Q3 2018 and held it in 15 quarters. The position peaked at $4.7M in Q4 2022. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.
- Holocene Advisors reported no remaining CONMED position as of Q1 2026 after selling out during the quarter.
- Holocene Advisors sold 11,463 CONMED shares in Q1 2026, an estimated $465K.
- Holocene Advisors first reported a position in CONMED in Q3 2018 and held it in 15 quarters.
- Holocene Advisors's CONMED position peaked at $4.7M in Q4 2022.
- 236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.
Based on Holocene Advisors's 13F filing for Q1 2026, filed 15 May 2026.